Announcements Trials
Browse Landscape

Phase

Phase NA 2Phase 2 1

Status

Completed 13Unknown 9Recruiting 7Terminated 3Active not recruiting 3Withdrawn 1Enrolling by invitation 1

Sponsor Class

OTHER 3

Study Type

Observational 3Interventional 3

Sponsor

Cancer Type

Thoracic 2Gastrointestinal 1

Conditions

Smoking Cessation 2Lung Neoplasms 2Rectal Neoplasms 1Pulmonary Disease, Chronic Obstructive 1Motor Activity 1Inflammation 1Cardiovascular Diseases 1

Interventions

pembrolizumab 438Carboplatin 321Nivolumab 293Cyclophosphamide 285Specimen Handling 257Paclitaxel 249Magnetic Resonance Spectroscopy 249Cisplatin 248Radiotherapy 218Dexamethasone 183Gemcitabine 177Biopsy 177durvalumab 169atezolizumab 149Doxorubicin 140Rituximab 138Lenalidomide 135Docetaxel 131Ipilimumab 130Bevacizumab 128Radiation 121Capecitabine 117Etoposide 116Oxaliplatin 114Fluorouracil 110Pemetrexed 109Radiosurgery 108fludarabine 106venetoclax 102Prednisone 97

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Active not recruiting × Interventional × Hematologic Tests × Clear all
NCT03654105 2026-03-27

SMILE

Fondazione IRCCS Istituto Nazionale dei Tumori, Milano

Phase 2 Active not recruiting
2,000 enrolled
Thoracic

Inflammation, Lung Neoplasms, Motor Activity, Smoking Cessation

NCT05766046 2026-03-27

RISP

Fondazione IRCCS Istituto Nazionale dei Tumori, Milano

Phase NA Active not recruiting
7,324 enrolled
Thoracic

Cardiovascular Diseases, Lung Neoplasms, Smoking Cessation, Pulmonary Disease, Chronic Obstructive

NCT06730035 2024-12-12

PRediction of Outcomes and PERsonalized Radiotherapy by Biomarkers and Functional Imaging

IRCCS Azienda Ospedaliero-Universitaria di Bologna

Phase NA Active not recruiting
30 enrolled
Gastrointestinal

Rectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡